Cargando…

Cognitive and Neuropsychiatric Symptom Differences in Early Stages of Alzheimer's Disease: Kuopio ALSOVA Study

BACKGROUND/AIM: Alzheimer's disease (AD) causes impairment in memory and other cognitive functions as well as neuropsychiatric symptoms and limitations in the activities of daily living (ADL). The aim of this study was to examine whether demographic variables, dementia severity, ADL and neurops...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hallikainen, Ilona, Koivisto, Anne M., Paajanen, Teemu, Hiltunen, Asta, Karppi, Pertti, Vanhanen, Matti, Välimäki, Tarja, Herukka, Sanna-Kaisa, Soininen, Hilkka, Hänninen, Tuomo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	S. Karger AG 2012
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3379731/ https://www.ncbi.nlm.nih.gov/pubmed/22719747 http://dx.doi.org/10.1159/000338231

Ejemplares similares

The Progression of Alzheimer's Disease Can Be Assessed with a Short Version of the CERAD Neuropsychological Battery: The Kuopio ALSOVA Study
por: Hallikainen, Ilona, et al.
Publicado: (2014)

Depressive Symptoms Are Associated with Analgesic Use in People with Alzheimer’s Disease: Kuopio ALSOVA Study
por: Gilmartin, Julia Fiona-Maree, et al.
Publicado: (2015)

Psychometric Properties of the Neuropsychiatric Inventory: A Review
por: Saari, Toni, et al.
Publicado: (2022)

Total cost of care increases significantly from early to mild Alzheimer’s disease: 5-year ALSOVA follow-up
por: Jetsonen, Viivi, et al.
Publicado: (2021)

Low Cerebrospinal Fluid Amyloid-Beta Concentration Is Associated with Poorer Delayed Memory Recall in Women
por: Haapalinna, Fanni, et al.
Publicado: (2016)

Genetic Loci Associated with Alzheimer’s Disease and Cerebrospinal Fluid Biomarkers in a Finnish Case-Control Cohort
por: Elias-Sonnenschein, Lyzel S., et al.
Publicado: (2013)

Metabolic Profiles Help Discriminate Mild Cognitive Impairment from Dementia Stage in Alzheimer’s Disease
por: Jääskeläinen, Olli, et al.
Publicado: (2020)

Predicting AD Conversion: Comparison between Prodromal AD Guidelines and Computer Assisted PredictAD Tool
por: Liu, Yawu, et al.
Publicado: (2013)

Using the Disease State Fingerprint Tool for Differential Diagnosis of Frontotemporal Dementia and Alzheimer's Disease
por: Muñoz-Ruiz, Miguel Ángel, et al.
Publicado: (2016)

Computer-based cognitive training for older adults: Determinants of adherence
por: Turunen, Merita, et al.
Publicado: (2019)

Plasma Aβ42 and Aβ40 as markers of cognitive change in follow-up: a prospective, longitudinal, population-based cohort study
por: Seppälä, T T, et al.
Publicado: (2010)

Decreased plasma C‐reactive protein levels in APOE ε4 allele carriers
por: Martiskainen, Henna, et al.
Publicado: (2018)

The CERAD Neuropsychological Battery in Patients with Frontotemporal Lobar Degeneration
por: Haanpää, Ramona M., et al.
Publicado: (2015)

A FinnGen pilot clinical recall study for Alzheimer’s disease
por: Julkunen, Valtteri, et al.
Publicado: (2023)

Rey's Auditory Verbal Learning Test scores can be predicted from whole brain MRI in Alzheimer's disease
por: Moradi, Elaheh, et al.
Publicado: (2016)

Cerebrospinal Fluid Biomarker and Brain Biopsy Findings in Idiopathic Normal Pressure Hydrocephalus
por: Pyykkö, Okko T., et al.
Publicado: (2014)

Vitamin D supplementation and serum neurofilament light chain in interferon‐beta‐1b‐treated MS patients
por: Hänninen, Katariina, et al.
Publicado: (2020)

Cerebrospinal Fluid Diagnostics of Alzheimer’s Disease in Patients with Idiopathic Normal Pressure Hydrocephalus
por: Vanninen, Aleksi, et al.
Publicado: (2023)

cCOG: A web‐based cognitive test tool for detecting neurodegenerative disorders
por: Rhodius‐Meester, Hanneke F.M., et al.
Publicado: (2020)

Associations of Depressive Symptoms and Cognition in the FINGER Trial: A Secondary Analysis of a Randomised Clinical Trial
por: Neuvonen, Elisa, et al.
Publicado: (2022)

Low Serum High-Density Lipoprotein Cholesterol Levels Associate with the C9orf72 Repeat Expansion in Frontotemporal Lobar Degeneration Patients
por: Jääskeläinen, Olli, et al.
Publicado: (2019)

Use of anti-dementia drugs in home care and residential care and associations with neuropsychiatric symptoms: a cross-sectional study
por: Kuronen, Marja, et al.
Publicado: (2015)

Detecting Amyloid Positivity in Elderly With Increased Risk of Cognitive Decline
por: Pekkala, Timo, et al.
Publicado: (2020)

Cognitive Performance among Cognitively Healthy Adults Aged 30–100 Years
por: Alenius, Minna, et al.
Publicado: (2019)

The Kuopio idiopathic normal pressure hydrocephalus protocol: initial outcome of 175 patients
por: Junkkari, A., et al.
Publicado: (2019)

Synaptic dysfunction and septin protein family members in neurodegenerative diseases
por: Marttinen, Mikael, et al.
Publicado: (2015)

Recurrence of arteriovenous malformations of the brain after complete surgical resection. Kuopio University Hospital experience and systematic review of the literature
por: Järvelin, Patrik, et al.
Publicado: (2023)

Regulation of key proteins in Alzheimer’s disease molecular pathogenesis by ubiquilin-1
por: Takalo, Mari, et al.
Publicado: (2013)

Baseline Telomere Length and Effects of a Multidomain Lifestyle Intervention on Cognition: The FINGER Randomized Controlled Trial
por: Sindi, Shireen, et al.
Publicado: (2017)

Recruitment and Baseline Characteristics of Participants in the Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability (FINGER)—A Randomized Controlled Lifestyle Trial †
por: Ngandu, Tiia, et al.
Publicado: (2014)

Telomere Length Change in a Multidomain Lifestyle Intervention to Prevent Cognitive Decline: A Randomized Clinical Trial
por: Sindi, Shireen, et al.
Publicado: (2020)

Alterations in mitochondria-endoplasmic reticulum connectivity in human brain biopsies from idiopathic normal pressure hydrocephalus patients
por: Leal, Nuno Santos, et al.
Publicado: (2018)

Associations of CAIDE Dementia Risk Score with MRI, PIB-PET measures, and cognition
por: Stephen, Ruth, et al.
Publicado: (2017)

CERAD Neuropsychological Total Scores Reflect Cortical Thinning in Prodromal Alzheimer's Disease
por: Paajanen, T., et al.
Publicado: (2013)

Tolerability of ORM-12741 and effects on episodic memory in patients with Alzheimer's disease
por: Rinne, Juha O., et al.
Publicado: (2016)

Modified serpinA1 as risk marker for Parkinson’s disease dementia: Analysis of baseline data
por: Halbgebauer, Steffen, et al.
Publicado: (2016)

Shortening of Saccades as a Possible Easy-to-Use Biomarker to Detect Risk of Alzheimer’s Disease
por: Hannonen, Sanna, et al.
Publicado: (2022)

Computer-based Eye-tracking Analysis of King-Devick Test Differentiates Persons With Idiopathic Normal Pressure Hydrocephalus From Cognitively Unimpaired
por: Lehtola, Juha-Matti, et al.
Publicado: (2022)

Elevated CSF LRG and Decreased Alzheimer’s Disease Biomarkers in Idiopathic Normal Pressure Hydrocephalus
por: Vanninen, Aleksi, et al.
Publicado: (2021)

Structural MRI in Frontotemporal Dementia: Comparisons between Hippocampal Volumetry, Tensor-Based Morphometry and Voxel-Based Morphometry
por: Muñoz-Ruiz, Miguel Ángel, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_ai7bn7o1755ccbo5bpmlqkaeco